Enable job alerts via email!
Boost your interview chances
Create a job specific, tailored resume for higher success rate.
An innovative clinical stage company is seeking a Scientist II in Radiochemistry to support the development of novel radiopharmaceuticals. This role involves synthesizing and analyzing radioconjugates, ensuring quality control, and collaborating across teams to advance oncology programs. The ideal candidate will have a strong background in radiochemistry and experience with various isotopes, contributing to groundbreaking cancer treatments. Join this forward-thinking organization and make a significant impact in the field of oncology.
2 days ago Be among the first 25 applicants
Radionetics Oncology, Inc. is a clinical stage company focused on the discovery and development of novel radiopharmaceuticals for the treatment of a wide range of oncology indications. Supported by prominent investors and in strategic partnership with Eli Lilly, Radionetics is advancing a pipeline of first-in-class small molecule radioligands targeting G protein-coupled receptors for cancers such as breast and lung cancer. For more information, visit https://radionetics.com.
The Scientist II, Radiochemistry supports in vivo and in vitro radioconjugate profiling and candidate selection for radiopharmaceutical development. This role requires expertise in radioconjugate synthesis, quality control, stability assessments, and data analysis, handling radioisotopes like Ga-68, In-111, Lu-177, among others. The Scientist II collaborates with various teams to develop solutions that advance multiple discovery programs and supports clinical production needs.
The position is based in San Diego, CA, with a non-standard work schedule, and may require travel. Radionetics offers a competitive compensation package including salary range of $130,000 – 160,000, benefits, and more. Radionetics is an equal opportunity employer committed to diversity and inclusion.